Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients With Hepatocellular Carcinoma

NCT05837065 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05837065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05837065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients With Hepatocellular Carcinoma
Lead sponsor
Zhejiang University
Phase
Observational
Overall status
Unknown status
Start date
September 15, 2022
Completion date
December 30, 2023
Enrollment
765 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma